Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Biochimica Et Biophysica Acta|November 13, 2007
Structural analysis of pituitary adenylate cyclase-activating polypeptides bound to phospholipid membranes by magic angle spinning solid-state NMRNobuyasu Komi, Kayo Okawa, Yukihiro Tateishi, et al.Acta Crystallographica. Section D, Biological Crystallography|September 2, 2015
Structural insights into the novel inhibition mechanism of Trypanosoma cruzi spermidine synthaseYasushi Amano, Ichiji Namatame, Yukihiro Tateishi, et al.FEBS Letters|December 21, 2005
The structure of the third intracellular loop of the muscarinic acetylcholine receptor M2 subtypeSusumu Ichiyama, Yoshiaki Oka, Kazuko Haga, et al.Journal of Medicinal Chemistry|February 17, 2016
An NMR Biochemical Assay for Fragment-Based Drug Discovery: Evaluation of an Inhibitor Activity on Spermidine Synthase of Trypanosoma cruziKazuhiko Yamasaki, Osamu Tani, Yukihiro Tateishi, et al.Protein Engineering, Design & Selection : PEDS|May 29, 2004
High-throughput construction method for expression vector of peptides for NMR study suited for isotopic labelingTakeshi Tenno, Natsuko Goda, Yukihiro Tateishi, et al.The Journal of Biological Chemistry|November 20, 2008
Molecular basis for SUMOylation-dependent regulation of DNA binding activity of heat shock factor 2Yukihiro Tateishi, Mariko Ariyoshi, Ryuji Igarashi, et al.ACS Omega|July 31, 2023
Discovery of a Hidden <i>Trypanosoma cruzi</i> Spermidine Synthase Binding Site and Inhibitors through <i>In Silico, In Vitro</i>, and X-ray CrystallographyRyunosuke Yoshino, Nobuaki Yasuo, Yohsuke Hagiwara, et al.Scientific Reports|July 29, 2017
In silico, in vitro, X-ray crystallography, and integrated strategies for discovering spermidine synthase inhibitors for Chagas diseaseRyunosuke Yoshino, Nobuaki Yasuo, Yohsuke Hagiwara, et al.Journal of Medicinal Chemistry|May 18, 2018
NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human EnzymesOsamu Tani, Yukie Akutsu, Shinji Ito, et al.Bioorganic & Medicinal Chemistry|April 13, 2020
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2Ikumi Kuriwaki, Minoru Kameda, Hiroyuki Hisamichi, et al.Pageof 2